I am perplexed by what seems to be a contradiction in conclusions drawn by the members of the Melanoma Center at the University of California, San Francisco, concerning prognosis of primary cutaneous melanoma. In a recent issue of the ARCHIVES, Shaikh et al write as follows1(p739):
The presence of microsatellites is intimately tied to other markers of melanoma aggressiveness. Microsatellites appear to predict locoregional relapse and RFS [relapse-free survival] but neither distant metastasis nor OS [overall survival].
Ackerman AB. A Seeming Failure of Logic. Arch Dermatol. 2006;142(2):244–245. doi:10.1001/archderm.142.2.244
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: